- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 55.27M sh |
| Shares Diluted | Q1 2026 · Apr 4, 2026 | 56M sh |
| Shares Diluted | Q1 2026 · Mar 29, 2025 | 56.06M sh |
| Stock Repurchased | Q1 2026 · Apr 4, 2026 | $25M |
| Stock Repurchased | Q1 2026 · Mar 29, 2025 | $0 |
| Dividends Paid | Q1 2026 · Apr 4, 2026 | $29.34M |
| Dividends Paid | Q1 2026 · Mar 29, 2025 | $28.82M |
| Capex | Q1 2026 · Apr 4, 2026 | $5.96M |
| Capex restated | Q1 2026 · Mar 29, 2025 | $2.32M |
| Operating Cash Flow | Q1 2026 · Apr 4, 2026 | $46.26M |
| Operating Cash Flow | Q1 2026 · Mar 29, 2025 | $77.63M |
| Long Term Debt | Q1 2026 · Apr 4, 2026 | $1.13B |
| Long Term Debt | Q1 2026 · Jan 3, 2026 | $1.13B |
| Long Term Debt | Q1 2026 · Mar 29, 2025 | $735.64M |
| Cash And Equivalents | Q1 2026 · Apr 4, 2026 | $56.41M |
| Cash And Equivalents | Q1 2026 · Jan 3, 2026 | $77.22M |
| Cash And Equivalents restated | Q1 2026 · Mar 29, 2025 | $320.79M |
| Stockholders Equity | Q1 2026 · Apr 4, 2026 | $618.87M |
| Stockholders Equity | Q1 2026 · Jan 3, 2026 | $564.87M |
| Stockholders Equity | Q1 2026 · Mar 29, 2025 | $426.67M |
| Stockholders Equity | Q1 2026 · Dec 28, 2024 | $400.06M |
| Current Liabilities | Q1 2026 · Apr 4, 2026 | $601.02M |
| Current Liabilities | Q1 2026 · Jan 3, 2026 | $593.63M |
| Current Liabilities | Q1 2026 · Mar 29, 2025 | $391.14M |
| Total Liabilities | Q1 2026 · Apr 4, 2026 | $2.03B |
| Total Liabilities | Q1 2026 · Jan 3, 2026 | $2.02B |
| Total Liabilities | Q1 2026 · Mar 29, 2025 | $1.25B |
| Current Assets | Q1 2026 · Apr 4, 2026 | $1.12B |
| Current Assets | Q1 2026 · Jan 3, 2026 | $1.08B |
| Current Assets | Q1 2026 · Mar 29, 2025 | $1.09B |
| Total Assets | Q1 2026 · Apr 4, 2026 | $2.65B |
| Total Assets | Q1 2026 · Jan 3, 2026 | $2.58B |
| Total Assets | Q1 2026 · Mar 29, 2025 | $1.68B |
| Eps Diluted | Q1 2026 · Apr 4, 2026 | $1.65 |
| Eps Diluted | Q1 2026 · Mar 29, 2025 | $0.76 |
| Eps Basic | Q1 2026 · Apr 4, 2026 | $1.67 |
| Eps Basic | Q1 2026 · Mar 29, 2025 | $0.77 |
| Sga Expense | Q1 2026 · Apr 4, 2026 | $239.27M |
| Sga Expense restated | Q1 2026 · Mar 29, 2025 | $161.37M |
| Net Income | Q1 2026 · Apr 4, 2026 | $92.44M |
| Net Income | Q1 2026 · Mar 29, 2025 | $42.88M |
| Operating Income | Q1 2026 · Apr 4, 2026 | $90.11M |
| Operating Income restated | Q1 2026 · Mar 29, 2025 | $31.37M |
| Cost Of Revenue | Q1 2026 · Apr 4, 2026 | $283.95M |
| Cost Of Revenue restated | Q1 2026 · Mar 29, 2025 | $230.27M |
| Revenue | Q1 2026 · Apr 4, 2026 | $613.32M |
| Revenue restated | Q1 2026 · Mar 29, 2025 | $423M |